Postoperative Pain in Shoulder Surgery

February 16, 2024 updated by: Ferda YAMAN, Eskisehir Osmangazi University

The Effect of Ultrasound-Guided Suprascapular Block Plus Low-dose Interscalen Brachial Plexus Block for Postoperative Pain in Shoulder Surgery

After the approval of the ethics committee, the files of the patients who underwent arthroscopic shoulder surgery between 01.01.2019 and 01.03.2020 were evaluated retrospectively.

Data were recorded including age, gender, duration of anesthesia, duration of surgery, postoperative analgesia consumption, complications such as respiratory distress due to hemidiaphragmatic paralysis and complications such as hematoma and nerve damage due to block intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Patients who underwent arthroscopic shoulder surgery and underwent USG-guided interscalene block and concomitant suprascapular block were included in the study. We tried to determine whether there is a difference between different dose regimens in order to determine the effective analgesic dose and minimize the side effects of dose-dependent interscalene block applications.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Odunpazarı
      • Eskişehir, Odunpazarı, Turkey, 26040
        • Ferda YAMAN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

>18 years old patients undergoing arthroscopic shoulder surgery by the same surgeon.

Description

Inclusion Criteria:

arthroscopic shoulder surgery full data form

Exclusion Criteria:

chronic obstructive lung disease chronic opoid consumption missing data from the postoperative pain form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
GROUP I
Interscalene block (group I)15 ml of 0.5% bupivacaine was applied with a single injection to 12 of 18 patients,
Other: perineural injection
perineural injection of local anesthestetic for postoperative pain management
GROUP II
7.5 ml of interscalene and 7.5 ml of suprascapular block (GROUP II) were applied to 6 patients with posterior approach.
Other: perineural injection
perineural injection of local anesthestetic for postoperative pain management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
rescue analgesia
Time Frame: between 01.01.2019 and 01.03.2020
postoperative pain score (VAS) > 4 required to rescue analgesia
between 01.01.2019 and 01.03.2020
difference between the analgesic methods
Time Frame: between 01.01.2019 and 01.03.2020
between 01.01.2019 and 01.03.2020

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eskisehir Osmangazi University

Investigators

  • Study Director: Ferda YAMAN, Assoc prof, University of Eskişehir Osmangazi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2020

Primary Completion (Actual)

June 15, 2021

Study Completion (Actual)

July 15, 2021

Study Registration Dates

First Submitted

September 11, 2023

First Submitted That Met QC Criteria

February 16, 2024

First Posted (Actual)

February 20, 2024

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 16, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EskisehirUO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

reterospectively completed

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on perineural injection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe